Ultralife Stock Price, News & Analysis

Ultralife Corporation (NASDAQ: ULBI) reported a second-quarter operating income of $1.1 million on $26.8 million in revenue, down from $28.6 million in Q2 2020. Despite a 3% sequential sales increase from Q1, year-over-year revenue decreased by 6.3%. Notably, oil & gas revenues surged by 49% year-over-year, while sales from government/defense dropped by 13.2%. Delayed shipments due to supply chain issues impacted revenue by approximately $1.5 million. Cash position improved by 15.9% to $15.8 million, while debt decreased by 36.6% to $0.7 million.

Ultralife Corporation (NASDAQ: ULBI) will announce its second quarter results for the period ending June 30, 2021, before market opening on July 29, 2021. Management will conduct a conference call at 8:30 AM ET on the same day. Investors can join by calling (800) 915-4836 or via a live webcast available on the company’s investor relations page. A replay of the webcast will be accessible shortly after the live event. Ultralife specializes in power solutions and communication systems, serving various global markets including government and defense.

Ultralife Corporation (NASDAQ: ULBI) has secured a firm-fixed price contract from the U.S. Army for Conformal Wearable Batteries, valued at up to $168 million over three years. The contract may extend to an additional $350 million based on one-year options. This award is part of a $1.25 billion program aimed at enhancing soldier mobility with lightweight batteries that sustain operations for up to 24 hours. Ultralife's selection underscores its reputation for reliability and safety in military applications.

Ultralife Corporation (NASDAQ: ULBI) reported a slight increase in revenue to $26.0 million for Q1 2021, up 0.6% year-over-year. Operating income fell to $1.0 million, down from $1.5 million in the same quarter last year. The company saw a 32% increase in medical device battery sales and 30% growth in government/defense sales, but these were offset by a 30% decline in oil & gas market sales and a 23.6% decrease in Communications Systems sales. Net income was $0.7 million or $0.04 per diluted share, reflecting $2.0 million adverse impact from COVID-19.

Ultralife Corporation (NASDAQ: ULBI) is set to announce its first quarter results for the period ending March 31, 2021, before the market opens on April 29, 2021. The management will follow with an investor conference call at 8:30 AM ET the same day. Interested participants can join the call by dialing (800) 915-4836. A live webcast will also be available on the company's website, with a replay accessible shortly after the call. Ultralife offers a range of products and services in power solutions and communication systems globally.

Ultralife Corporation (NASDAQ: ULBI) reported mixed Q4 2020 results with revenue of $29.0 million, down 6.6% from $31.0 million in Q4 2019. GAAP EPS increased to $0.13 from $0.10, while Adjusted EPS rose to $0.17 from $0.13. Operating income dropped to $1.2 million from $2.5 million amid a $2.6 million negative impact from COVID-19. Medical battery sales surged 94%, but oil & gas market sales fell 67.4%. The company's debt was reduced by 91.5% to $1.5 million, and cash-on-hand grew 43.9% to $10.7 million, highlighting resilience amidst challenges.

Ultralife Corporation (NASDAQ: ULBI) is set to report its fourth quarter results for the fiscal year ending December 31, 2020, on February 4, 2021, before the market opens. Management will host an investor conference call at 8:30 AM ET on the same day, accessible via phone or a live webcast. The call aims to engage with investors, providing an overview of the company’s performance. Ultralife specializes in power solutions and communications systems, serving government, defense, and commercial sectors globally.

Ultralife Corporation (NASDAQ: ULBI) reported a third-quarter operating income of $0.7 million on revenue of $24.4 million for the period ending September 30, 2020. Revenue decreased by 11.4% from $27.5 million last year, with operating income down from $1.3 million. Medical sales surged 102%, but were countered by weak oil & gas market performance and a 48.3% decline in Communications Systems sales. Despite challenges from COVID-19, the company reduced debt by $7.1 million and increased cash reserves by $5.4 million, asserting a solid balance sheet amid ongoing economic pressures.

Ultralife Corporation (NASDAQ: ULBI) is set to release its third quarter financial results for the period ending September 30, 2020, on October 29, 2020, before market opening. Management will hold an investor conference call and webcast at 8:30 AM ET on the same day. Participants can join the call by dialing (800) 915-4836 and a replay will be available shortly after. Ultralife specializes in power solutions and communication systems for government, defense, and commercial customers globally, with operations across North America, Europe, and Asia.